English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Novartis
Patient Daily
| May 7, 2023
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily
| May 7, 2023
Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Patient Daily
| May 7, 2023
Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Patient Daily
| May 7, 2023
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Carol Ostrow
| Feb 7, 2019
Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara
Press release submission
| Dec 5, 2018
NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
Press releases submission
| May 15, 2018
NOVARTIS: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Carrie Bradon
| Dec 1, 2017
Novartis announces positive results of MONALEESA-7 trial
Trending
+
Pharmaceuticals
Patient Daily
| Feb 19, 2025
American Lung Association hosts Fight For Air Climb in Los Angeles
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
South Florida firefighter aims to defeat lung disease through annual stair climb
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
Expert tips for managing springtime allergies effectively
+
Regulatory
Patient Daily
| Feb 14, 2025
Spokesperson for Patients Come First: 340B program is ‘one of the most blatant abuses of a governmental program’
1
2
3
»
Last »
